All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Abstract

Development of Colon-targeted Microsponges for the Treatment of Inflammatory Bowel Disease

Author(s): S. Janakidevi* and K. V. Ramanamurthy
A. U. College of Pharmaceutical Sciences, Andhra University, Visakhapatnam-530 003, India

Correspondence Address:
A. U. College of Pharmaceutical Sciences, Andhra University, Visakhapatnam-530 003, India, E-mail: [email protected]


The present study is aimed to develop and characterize microsponge-based novel colon-specific drug delivery systems containing 5-amino salicylic acid for the treatment of inflammatory bowel disease. Initially, microsponges of 5-amino salicylic acid were prepared by quasi-emulsion solvent diffusion method using Eudragit RS100, Eudragit S-100 and Eudragit L100. Different formulations of microsponges using three acid resistant polymers, Eudragit S100, Eudragit L100, Eudragit RS100 in drug:polymer ratios of 1:1, 1:0.5, 1:0.25 with each polymer were prepared and evaluated for physicochemical, morphological characteristics and in vitro parameters. Among these nine formulations, ES1, EL1 and ERS1 were selected, sieved and compressed into tablets, T-ES1, T-EL1, T-ERS1 and evaluated. Among the 3 batches of tablet formulations prepared, T-ES1 showed the best release rate for the drug, which followed zero order release kinetics with diffusion case II transport mechanism.

Full-Text | PDF